Now showing items 1-2 of 2
Comparison of hematopoietic stem cell transplantation results in patients with beta-thalassemia major from three different graft types
(Taylor & Francis Ltd, 2021)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for beta-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord ...
Busulfan–fudarabine‑ or treosulfan–fudarabine‑based myeloablative conditioning for children with thalassemia major
(Annals of Hematology, 2021)
Signifcant advances in supportive care for patients with transfusion-dependent thalassemia major (TDT) have improved patients’ life expectancy. However, transfusion-associated iron overload remains a signifcant barrier ...